WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
Portfolio Pulse from Chris Katje
The World Health Organization (WHO) has declared an international public health emergency over mpox due to a significant rise in cases, particularly in Africa. This has led to increased trading activity in stocks related to mpox vaccines and treatments, including Bavarian Nordic, Emergent Biosolutions, GeoVax Labs, and SIGA Technologies.

August 14, 2024 | 8:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bavarian Nordic shares surged 32.52% after WHO declared mpox a public health emergency. The company recently secured a $157-million contract to replenish the U.S. supply of its Jynneos vaccine.
The WHO's declaration of a public health emergency has increased demand for mpox vaccines, directly benefiting Bavarian Nordic, which has a significant contract to supply the U.S. with its Jynneos vaccine.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Emergent Biosolutions shares rose 11.65% following the WHO's declaration. The company produces the ACAM2000 vaccine and Tembexa, a potential treatment for mpox.
The WHO's declaration has heightened the need for mpox vaccines and treatments, positively impacting Emergent Biosolutions, which produces the ACAM2000 vaccine and Tembexa treatment.
CONFIDENCE 100
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
GeoVax Labs shares increased by 24% as the WHO declared mpox a public health emergency. The company has a mpox vaccine in clinical development.
GeoVax Labs is developing a mpox vaccine, and the WHO's declaration has increased investor interest in companies working on mpox-related solutions.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
SIGA Technologies shares rose 28% following the WHO's declaration. The company produces Tpoxx, a treatment for mpox.
The WHO's declaration has increased the demand for mpox treatments, benefiting SIGA Technologies, which produces Tpoxx.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80